Roots Analysis

Roots Analysis has announced the addition of “Non-Tyrosine Kinase Inhibitors in Oncology, 2015-2025” report to their offering.

Roots Analysis has announced the addition of “Companion Diagnostics Market, 2014 - 2024 (2nd edition)” report to their offering. The study offers an extensive analysis of this growing market, including market forecasts for the period 2014-2024.

Roots Analysis has announced the addition of “HPAPIs and Cytotoxic Drugs Manufacturing Market” report to their portfolio. The report provides an extensive study of the contract manufacturing opportunity for this rapidly expanding market.

The report provides an extensive study of the contract manufacturing opportunity for this emerging class of therapeutics. It identifies various CMOs active in this space, their capabilities with respect to ADCs and the location of the facilities.

The report provides a comprehensive study of the pipeline drugs being developed for rare diseases by several top pharmaceutical firms.

The focus of the latest edition is to provide a comprehensive analysis of the current state of the market, including detailed sales forecasts of these devices over the next ten years.

Roots Analysis has announced the addition of "Immune Checkpoint Inhibitors Market - 2014 - 2024" report to their offering.